ACADACADIA Pharmaceuticals Inc.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −17% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 30, 2026, a few days of normal trading to cover. Down 14% since the previous count, down from 6.4% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ACAD is trading
ACADIA Pharmaceuticals Inc. is −4.4% over the past year while the S&P 500 is +16%: 20 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −17%
vs 200-day average · a clear downtrend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-23
- $19.71
- 1 monthS&P 500 −0.94%
- −11%
- 1 yearS&P 500 +16%
- −4.4%
- 5 yearsS&P 500 +86%
- +13%
- vs 50-day average$24.61
- −20%
- 52-week high
- $30.57
- 52-week low
- $18.62
- Annualised volatility
- 45%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $652K
| Year | Return |
|---|---|
| 2026 (year to date) | −26% |
| 2025 | +46% |
| 2024 | −41% |
| 2023 | +97% |
| 2022 | −32% |
| 2021 | −56% |
| 2020 | +25% |
| 2019 | +165% |
| 2018 | −46% |
| 2017 | +4.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +3.8% |
| Feb | 10 | 7 of 10 | +3.3% |
| Mar | 10 | 1 of 10 | −13% |
| Apr | 10 | 3 of 10 | −7.8% |
| May | 10 | 5 of 10 | +3.3% |
| Jun | 10 | 6 of 10 | +2.5% |
| Jul | 11 | 7 of 11 | +3.9% |
| Aug | 11 | 5 of 11 | +0.08% |
| Sep | 11 | 4 of 11 | +0.11% |
| Oct | 11 | 5 of 11 | +0.32% |
| Nov | 10 | 6 of 10 | +5.4% |
| Dec | 10 | 6 of 10 | +6.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.